ID   GGH_HUMAN               Reviewed;         318 AA.
AC   Q92820;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 2.
DT   10-MAY-2017, entry version 155.
DE   RecName: Full=Gamma-glutamyl hydrolase;
DE            EC=3.4.19.9;
DE   AltName: Full=Conjugase;
DE   AltName: Full=GH;
DE   AltName: Full=Gamma-Glu-X carboxypeptidase;
DE   Flags: Precursor;
GN   Name=GGH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8816764; DOI=10.1073/pnas.93.19.10134;
RA   Yao R., Schneider E., Ryan T.J., Galivan J.;
RT   "Human gamma-glutamyl hydrolase: cloning and characterization of the
RT   enzyme expressed in vitro.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:10134-10138(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10570974; DOI=10.1016/S0378-1119(99)00362-5;
RA   Yin D., Chave K.J., Macaluso C.R., Galivan J., Yao R.;
RT   "Structural organization of the human gamma-glutamyl hydrolase gene.";
RL   Gene 238:463-470(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   MUTAGENESIS OF CYS-134.
RX   PubMed=10527932; DOI=10.1042/bj3430551;
RA   Chave K.J., Galivan J., Ryan T.J.;
RT   "Site-directed mutagenesis establishes cysteine-110 as essential for
RT   enzyme activity in human gamma-glutamyl hydrolase.";
RL   Biochem. J. 343:551-555(1999).
RN   [5]
RP   MUTAGENESIS OF CYS-134; HIS-244 AND GLU-246, AND 3D-STRUCTURE
RP   MODELING.
RX   PubMed=11005824; DOI=10.1074/jbc.M007908200;
RA   Chave K.J., Auger I.E., Galivan J., Ryan T.J.;
RT   "Molecular modeling and site-directed mutagenesis define the catalytic
RT   motif in human gamma -glutamyl hydrolase.";
RL   J. Biol. Chem. 275:40365-40370(2000).
RN   [6]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [7]
RP   SUBUNIT.
RX   PubMed=16945597; DOI=10.1016/j.bbapap.2006.06.008;
RA   Eisele L.E., Chave K.J., Lehning A.C., Ryan T.J.;
RT   "Characterization of human gamma-glutamyl hydrolase in solution
RT   demonstrates that the enzyme is a non-dissociating homodimer.";
RL   Biochim. Biophys. Acta 1764:1479-1486(2006).
RN   [8]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 25-318, IDENTIFICATION BY
RP   MASS SPECTROMETRY, GLYCOSYLATION AT ASN-163; ASN-203 AND ASN-307, AND
RP   SUBUNIT.
RX   PubMed=11953431; DOI=10.1074/jbc.M202020200;
RA   Li H., Ryan T.J., Chave K.J., Van Roey P.;
RT   "Three-dimensional structure of human gamma -glutamyl hydrolase. A
RT   class I glutamine amidotransferase adapted for a complex substate.";
RL   J. Biol. Chem. 277:24522-24529(2002).
CC   -!- FUNCTION: Hydrolyzes the polyglutamate sidechains of
CC       pteroylpolyglutamates. Progressively removes gamma-glutamyl
CC       residues from pteroylpoly-gamma-glutamate to yield pteroyl-alpha-
CC       glutamate (folic acid) and free glutamate. May play an important
CC       role in the bioavailability of dietary pteroylpolyglutamates and
CC       in the metabolism of pteroylpolyglutamates and antifolates.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of a gamma-glutamyl bond.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11953431,
CC       ECO:0000269|PubMed:16945597}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000305}.
CC       Lysosome {ECO:0000269|PubMed:12643545}. Melanosome
CC       {ECO:0000269|PubMed:12643545}. Note=While its intracellular
CC       location is primarily the lysosome, most of the enzyme activity is
CC       secreted. Identified by mass spectrometry in melanosome fractions
CC       from stage I to stage IV. {ECO:0000269|PubMed:12643545}.
CC   -!- SIMILARITY: Belongs to the peptidase C26 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GGHID44358ch8q12.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U55206; AAC05579.1; -; mRNA.
DR   EMBL; AF147083; AAF03360.1; -; Genomic_DNA.
DR   EMBL; AF147081; AAF03360.1; JOINED; Genomic_DNA.
DR   EMBL; AF147082; AAF03360.1; JOINED; Genomic_DNA.
DR   EMBL; BC025025; AAH25025.1; -; mRNA.
DR   CCDS; CCDS6177.1; -.
DR   PIR; JC6115; JC6115.
DR   RefSeq; NP_003869.1; NM_003878.2.
DR   UniGene; Hs.78619; -.
DR   PDB; 1L9X; X-ray; 1.60 A; A/B/C/D=25-318.
DR   PDBsum; 1L9X; -.
DR   ProteinModelPortal; Q92820; -.
DR   SMR; Q92820; -.
DR   BioGrid; 114363; 25.
DR   IntAct; Q92820; 3.
DR   STRING; 9606.ENSP00000260118; -.
DR   BindingDB; Q92820; -.
DR   ChEMBL; CHEMBL2223; -.
DR   DrugBank; DB00158; Folic Acid.
DR   DrugBank; DB00563; Methotrexate.
DR   MEROPS; C26.001; -.
DR   iPTMnet; Q92820; -.
DR   PhosphoSitePlus; Q92820; -.
DR   BioMuta; GGH; -.
DR   DMDM; 6016127; -.
DR   EPD; Q92820; -.
DR   MaxQB; Q92820; -.
DR   PaxDb; Q92820; -.
DR   PeptideAtlas; Q92820; -.
DR   PRIDE; Q92820; -.
DR   DNASU; 8836; -.
DR   Ensembl; ENST00000260118; ENSP00000260118; ENSG00000137563.
DR   GeneID; 8836; -.
DR   KEGG; hsa:8836; -.
DR   UCSC; uc003xuw.4; human.
DR   CTD; 8836; -.
DR   DisGeNET; 8836; -.
DR   GeneCards; GGH; -.
DR   HGNC; HGNC:4248; GGH.
DR   HPA; CAB019296; -.
DR   HPA; HPA025226; -.
DR   MalaCards; GGH; -.
DR   MIM; 601509; gene.
DR   neXtProt; NX_Q92820; -.
DR   OpenTargets; ENSG00000137563; -.
DR   Orphanet; 306574; Methotrexate dose selection.
DR   PharmGKB; PA432; -.
DR   eggNOG; KOG1559; Eukaryota.
DR   eggNOG; ENOG410XQKI; LUCA.
DR   GeneTree; ENSGT00490000043388; -.
DR   HOGENOM; HOG000006721; -.
DR   HOVERGEN; HBG005833; -.
DR   InParanoid; Q92820; -.
DR   KO; K01307; -.
DR   OMA; APYEWKN; -.
DR   OrthoDB; EOG091G0E82; -.
DR   PhylomeDB; Q92820; -.
DR   TreeFam; TF323437; -.
DR   BRENDA; 3.4.19.9; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   EvolutionaryTrace; Q92820; -.
DR   GeneWiki; GGH_(gene); -.
DR   GenomeRNAi; 8836; -.
DR   PRO; PR:Q92820; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000137563; -.
DR   CleanEx; HS_GGH; -.
DR   Genevisible; Q92820; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:1904724; C:tertiary granule lumen; TAS:Reactome.
DR   GO; GO:0008238; F:exopeptidase activity; TAS:ProtInc.
DR   GO; GO:0034722; F:gamma-glutamyl-peptidase activity; IDA:UniProtKB.
DR   GO; GO:0008242; F:omega peptidase activity; TAS:ProtInc.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:InterPro.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0010043; P:response to zinc ion; IEA:Ensembl.
DR   Gene3D; 3.40.50.880; -; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR015527; Pept_C26_g-glut_hydrolase.
DR   InterPro; IPR011697; Peptidase_C26.
DR   PANTHER; PTHR11315; PTHR11315; 1.
DR   Pfam; PF07722; Peptidase_C26; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   PROSITE; PS51275; PEPTIDASE_C26_GGH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Glycoprotein; Hydrolase; Lysosome;
KW   Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     24       {ECO:0000250}.
FT   CHAIN        25    318       Gamma-glutamyl hydrolase.
FT                                /FTId=PRO_0000026539.
FT   DOMAIN       25    318       Gamma-glutamyl hydrolase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00607}.
FT   ACT_SITE    134    134       Nucleophile.
FT   ACT_SITE    244    244       Proton donor.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    163    163       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11953431}.
FT   CARBOHYD    203    203       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:11953431}.
FT   CARBOHYD    307    307       N-linked (GlcNAc...) asparagine; partial.
FT                                {ECO:0000269|PubMed:11953431}.
FT   VARIANT       6      6       C -> R (in dbSNP:rs1800909).
FT                                /FTId=VAR_014697.
FT   VARIANT      31     31       A -> T (in dbSNP:rs11545077).
FT                                /FTId=VAR_029230.
FT   VARIANT     151    151       T -> I (in dbSNP:rs11545078).
FT                                /FTId=VAR_029231.
FT   MUTAGEN     134    134       C->A: Loss of activity.
FT                                {ECO:0000269|PubMed:10527932,
FT                                ECO:0000269|PubMed:11005824}.
FT   MUTAGEN     195    195       H->N: Reduces activity 250-fold.
FT   MUTAGEN     244    244       H->A: Loss of activity.
FT                                {ECO:0000269|PubMed:11005824}.
FT   MUTAGEN     246    246       E->A: Slightly reduced catalytic
FT                                activity. {ECO:0000269|PubMed:11005824}.
FT   STRAND       35     39       {ECO:0000244|PDB:1L9X}.
FT   HELIX        46     49       {ECO:0000244|PDB:1L9X}.
FT   STRAND       53     57       {ECO:0000244|PDB:1L9X}.
FT   HELIX        58     66       {ECO:0000244|PDB:1L9X}.
FT   STRAND       70     74       {ECO:0000244|PDB:1L9X}.
FT   HELIX        80     89       {ECO:0000244|PDB:1L9X}.
FT   STRAND       90     95       {ECO:0000244|PDB:1L9X}.
FT   TURN        102    104       {ECO:0000244|PDB:1L9X}.
FT   HELIX       106    123       {ECO:0000244|PDB:1L9X}.
FT   STRAND      130    133       {ECO:0000244|PDB:1L9X}.
FT   HELIX       135    145       {ECO:0000244|PDB:1L9X}.
FT   STRAND      151    160       {ECO:0000244|PDB:1L9X}.
FT   TURN        167    170       {ECO:0000244|PDB:1L9X}.
FT   TURN        173    176       {ECO:0000244|PDB:1L9X}.
FT   HELIX       179    187       {ECO:0000244|PDB:1L9X}.
FT   STRAND      191    198       {ECO:0000244|PDB:1L9X}.
FT   HELIX       201    205       {ECO:0000244|PDB:1L9X}.
FT   HELIX       208    213       {ECO:0000244|PDB:1L9X}.
FT   STRAND      214    224       {ECO:0000244|PDB:1L9X}.
FT   STRAND      226    236       {ECO:0000244|PDB:1L9X}.
FT   STRAND      238    243       {ECO:0000244|PDB:1L9X}.
FT   HELIX       247    250       {ECO:0000244|PDB:1L9X}.
FT   HELIX       262    279       {ECO:0000244|PDB:1L9X}.
FT   HELIX       289    295       {ECO:0000244|PDB:1L9X}.
FT   HELIX       297    299       {ECO:0000244|PDB:1L9X}.
FT   TURN        306    308       {ECO:0000244|PDB:1L9X}.
FT   STRAND      312    317       {ECO:0000244|PDB:1L9X}.
SQ   SEQUENCE   318 AA;  35964 MW;  C4069953573B9B24 CRC64;
     MASPGCLLCV LGLLLCGAAS LELSRPHGDT AKKPIIGILM QKCRNKVMKN YGRYYIAASY
     VKYLESAGAR VVPVRLDLTE KDYEILFKSI NGILFPGGSV DLRRSDYAKV AKIFYNLSIQ
     SFDDGDYFPV WGTCLGFEEL SLLISGECLL TATDTVDVAM PLNFTGGQLH SRMFQNFPTE
     LLLSLAVEPL TANFHKWSLS VKNFTMNEKL KKFFNVLTTN TDGKIEFIST MEGYKYPVYG
     VQWHPEKAPY EWKNLDGISH APNAVKTAFY LAEFFVNEAR KNNHHFKSES EEEKALIYQF
     SPIYTGNISS FQQCYIFD
//
